The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

Category

Minimum severity

Clear filters

16651–16675 of 18042

  • SevereFDA (Drugs)·D-1066-2013·2013-10-09

    AmeriSource Bergen Recalls Ifosfamide Injection Due to Temperature Abuse

    AmeriSource Bergen is recalling specific lots of Ifosfamide Injection because they were not refrigerated at certain distribution centers.

    Product
    Ifosfamide Injection 3g/60 mL, Single dose vial, Rx only, Sterile, For Intravenous Use, Refrigerate at 2-8 degrees celcius, Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY 10017, NDC 0069-4496-22
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1069-2013·2013-10-09

    Triangle Compounding Recalls Histamine Injectable Due to Sterility Concerns

    Triangle Compounding Pharmacy is recalling 8 vials of Histamine, 10 ng/mL Injectable due to laboratory results indicating microbial contamination and concerns about the reliability of sterility testing.

    Product
    Histamine, 10 ng/mL Injectable, MDV, Rx only, Triangle Compounding Pharmacy, 3700 Regency Parkway, Suite 140, Cary NC 27518.
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-66251-001·2013-10-09

    Watson Recalls Oxycodone and Acetaminophen Tablets Due to Foreign Contamination

    Watson Laboratories is recalling Oxycodone and Acetaminophen Tablets because foreign tablets were found in a sealed bottle.

    Product
    Oxycodone and Acetaminophen Tablets, USP 10 mg/650 mg, CII, 100 Count Bottles, Rx Only, Manufactured by: Watson Laboratories, Inc. Corona, CA 92880 USA, NDC 0591-0825-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1064-2013·2013-10-09

    Marlex Acetaminophen Tablets Recalled for Manufacturing Practice Deviations

    Marlex Pharmaceuticals is recalling 28,387 bottles of Acetaminophen Tablets, 500 mg, because the lot was not manufactured under current good manufacturing practices.

    Product
    Acetaminophen Tablets, 500 mg, 100-count bottles, Distributed by: Marlex Pharmaceuticals, Inc., New Castle, DE 19720, List No. 152, NDC 10135-152-01, UPC 3 10135 15201 8.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-1067-2013·2013-10-09

    Osmotica Recalls Venlafaxine Extended Release Tablets for Dissolution Failure

    Osmotica Pharmaceutical Corp. is recalling specific lots of Venlafaxine extended release tablets because they failed to meet dissolution specifications at 18 months.

    Product
    Venlafaxine (Venlafaxine Hydrochloride) extended release Tablets, 225 mg, packaged in a) 30- count bottle (NDC 0131-3268-32) and b) 90-count bottle (NDC: 0131-3268-46), Rx only, Manufactured by: Kremers Urban Pharmaceuticals Inc. For: Osmotica Pharmaceutical Corp., Wilmington…
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1063-2013·2013-10-02

    Walgreens Recalls Progesterone Injection Lot Due to Sterility Concerns

    Walgreens Specialty Pharmacy is recalling one lot of Progesterone in Ethyl Oleate injection due to sterility assurance concerns with its testing laboratory.

    Product
    Walgreens Progesterone in Ethyl Oleate 50 mg per mL Injection, 10 mL vial, Inject 1 mL Intramuscularly as directed by physician, Walgreens Specialty Pharmacy, Fresco, TX.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1062-2013·2013-10-02

    CorePharma Recalls Pyridostigmine Bromide Tablets Due to Stability Failure

    CorePharma is recalling 960 bottles of Pyridostigmine Bromide Tablets 60 mg because stability testing showed out-of-specification results.

    Product
    Pyridostigmine Bromide Tablets 60 mg, USP Rx Only 100 Tablets, Manufactured and Distributed by: CorePharma, LLC Middlesex, NJ 08846 NDC 64720-128-10 NDC 64720-128-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1050-2013·2013-09-25

    Medaus Recalls Taurine 50 mg/mL PF Due to Sterility Concerns

    Medaus, Inc. is recalling Taurine 50 mg/mL PF, 100 mL, due to laboratory results indicating microbial contamination and concerns about the reliability of sterility testing.

    Product
    Taurine 50 mg/mL PF, 100 mL, Medaus Pharmacy 1-800-526-9183
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1045-2013·2013-09-25

    JCB Labs Recalls Sodium Citrate Injection Due to Sterility Concerns

    JCB Labs LLC is recalling 397 vials of Sodium Citrate 4% with Gentamicin due to potential microbial contamination and unreliable sterility test results.

    Product
    Sodium Citrate 4% containing Gentamicin 320 mcg/mL, Solution for Injection, 30 mL Multi Dose Vial, Sterile Solution For Office Use Only, JCB Laboratories, Wichita, KS.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1046-2013·2013-09-25

    JCB Labs Recalls Sodium Citrate Injection Vials Due to Sterility Concerns

    JCB Labs LLC is recalling 677 vials of Sodium Citrate 4% Solution for Injection because laboratory results indicate microbial contamination and sterility cannot be assured.

    Product
    Sodium Citrate 4% Solution for Injection, 30 mL Multi Dose Vial, Sterile Solution for Office Use Only, JCB Laboratories, Wichita, KS.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1040-2013·2013-09-25

    Leiter's Pharmacy Recalls Bevacizumab Syringes Due to Sterility Concerns

    Leiter's Pharmacy is recalling 265 vials of compounded Bevacizumab (Avastin) because a testing lab reported failed sterility results as passing, making the product's sterility unassured.

    Product
    Bevacizumab (Avastin) 2.5mg/0.1mL PF Inj., 0.1 mL syringe, Compounded by Leiter's Compounding Pharmacy, 1700 Park Ave., # 30, San Jose, CA 95126
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1059-2013·2013-09-25

    Avella Recalls Vancomycin and Bevacizumab Due to Sterility Concerns

    Avella Specialty Pharmacy is recalling vancomycin and bevacizumab products due to concerns about sterility assurance with its independent testing laboratory.

    Product
    Vancomycin PF (BSS) 1%, 1 mL, Avella Specialty Pharmacy, Phoenix, AZ 85085, 877-782-7684
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1041-2013·2013-09-25

    Leiter's Pharmacy Recalls Lidocaine/Phenylephrine Vials Due to Sterility Concerns

    Leiter's Pharmacy is recalling 728 vials of Lidocaine/Phenylephrine PF 1%/1.5% injectible solution because sterility cannot be assured after failed test results were incorrectly reported as passing.

    Product
    Lidocaine/Phenylephrine PF 1%/1.5% Injectible vials, 1 mL Single Use Vial, Compounded by Leiter's Compounding Pharmacy, 1700 Park Ave., # 30, San Jose, CA 95126
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1047-2013·2013-09-25

    JCB Labs Recalls Epinephrine Syringes Due to Sterility Concerns

    JCB Labs LLC is recalling 1,243 epinephrine syringes because laboratory results indicate microbial contamination and the sterility of the product cannot be assured.

    Product
    Epinephrine 1:1,000 (1mg/mL) Sterile Solution for injection, Preservative Free/Sulfite Free, 1-mL Single-Use Syringe, Sterile Solution For Office Use Only, JCB Laboratories, Wichita, KS.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1038-2013·2013-09-25

    Leiter's Pharmacy Recalls Dextrose 50% Injection Vials Due to Sterility Concerns

    Leiter's Pharmacy is recalling 56 vials of Dextrose 50% Injection Solution because sterility cannot be assured after testing errors were discovered.

    Product
    Dextrose 50% Preservative Free SDV Injection Solution, 50 mL Single dose vial, IV Administration, Compounded by Leiter's Compounding Pharmacy, 1700 Park Ave., # 30, San Jose, CA 95126
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1044-2013·2013-09-25

    JCB Labs Recalls Sodium Thiosulfate Injection Due to Sterility Concerns

    JCB Labs LLC is recalling 1,056 vials of Sodium Thiosulfate 25% injection because laboratory results indicate microbial contamination and sterility cannot be assured.

    Product
    Sodium Thiosulfate 25%, 250 mg/mL (12.5 g/50mL), PF Sterile Solution for Injection, 50 mL Single Dose Vial, For Office Use Only, JCB Laboratories, Wichita, KS.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1048-2013·2013-09-25

    Medaus Recalls Testosterone Cyp 200 mg/mL Due to Sterility Concerns

    Medaus, Inc. is recalling Testosterone Cyp 200 mg/mL injections because laboratory results indicate microbial contamination and the sterility of the product cannot be assured.

    Product
    Testosterone Cyp 200 mg/mL, W/Pres. (Benzyl ETOH), 3 mL, Medaus pharmacy 1-800-526-9183
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1054-2013·2013-09-25

    Medaus Recalls Sodium Ascorbate Injection Due to Sterility Concerns

    Medaus, Inc. is recalling 15,500 mL of Sodium Ascorbate 500 mg/mL injection due to laboratory results indicating microbial contamination and concerns about the reliability of sterility testing.

    Product
    NA Ascorbate 500 mg/mL, PF, 100 mL, Medaus Pharmacy 1-800-526-9183
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1052-2013·2013-09-25

    Medaus Recalls Pyridoxine HCL Due to Sterility Concerns

    Medaus, Inc. is recalling Pyridoxine HCL 100 mg/mL due to laboratory results indicating microbial contamination and concerns about the reliability of sterility testing.

    Product
    Pyridoxine HCL 100 mg/mL NS (PF), 30 mL, Medaus Pharmacy 1-800-526-9183
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1055-2013·2013-09-25

    Medaus Recalls NA Ascorbate Injection Due to Sterility Concerns

    Medaus, Inc. is recalling NA Ascorbate 500 mg/mL injection due to laboratory results indicating microbial contamination and concerns about the reliability of sterility testing.

    Product
    NA Ascorbate 500 mg/mL, non corn PF, 100ML, Medaus Pharmacy, 1-800-526-9183
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1053-2013·2013-09-25

    Medaus Recalls Magnesium Chloride Injection Due to Sterility Concerns

    Medaus, Inc. is recalling Magnesium Chloride 200 mg/mL PF, 100 mL vials due to laboratory results indicating microbial contamination and concerns about the reliability of sterility testing.

    Product
    Magnesium Chl 200 mg/mL PF, 100 mL, Medaus Pharmacy 1-800-526-9183
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1039-2013·2013-09-25

    Leiter's Pharmacy Recalls Hyaluronidase Vials Due to Sterility Concerns

    Leiter's Pharmacy is recalling 810 vials of Hyaluron (hyaluronidase) 150 units/mL due to bacterial contamination and unverified sterility.

    Product
    Hyaluron (hyaluronidase) 150 units/mL Preserved Solution, 1 mL, Multi Dose Vial, Compounded by Leiter's Compounding Pharmacy, 1700 Park Ave., # 30, San Jose, CA 95126
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1043-2013·2013-09-25

    JCB Labs Recalls Acetylcysteine Solution Due to Sterility Concerns

    JCB Labs LLC is recalling 903 vials of Acetylcysteine 20% Solution because laboratory results indicate microbial contamination and the sterility of the product cannot be assured.

    Product
    Acetylcysteine 20% Solution, Preservative Free, 4 mL Sterile Single Dose Vial, Not for Injection, Sterile Solution For Office Use Only, JCB Laboratories, Wichita, KS.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1049-2013·2013-09-25

    Medaus Recalls Lipo-Injection Due to Sterility Concerns

    Medaus, Inc. is recalling specific lots of Lipo-Injection w/ Lidocaine because laboratory results indicate microbial contamination and sterility cannot be assured.

    Product
    Lipo-Injection w/ Lidocaine (PF), Ascorbic Acid 50 mg; B1-50 mg; B2-5-PO4-5 mg; B3-50 mg; B5-5 mg; B6-5 mg; Cyano B12-100 mcg; Methionine 12.5 mg; Inositol-25 mg; Choline-25 mg; Lidocaine 10 mg/mL, 30 mL, Medaus Pharmacy 1-800-526-9183
    Category
    Drug
    Distribution
    Distributed nationwide